A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Clinical trial NCT07029399 · RECRUITING

Trial details

NCT number: NCT07029399
Sponsor: NiKang Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HR+ Breast Cancer Triple Negative Breast Cancer (TNBC)CCNE1 Amplified Advanced Solid Tumors HR+ HER2- Breast Cancer

Start date: 2025-03-25
Primary completion: 2027-07-31
Enrollment: 361

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.